Interestingly, previous work from our lab showed that ONC201 treatment led to a decrease in c-FLIP expression in colorectal cancer cells [28] and that IAP and Bcl-2 family proteins may play a role in tumor cell sensitivity to ONC201 [29]. This evidence concerns the gene CFLAR and neoplasm.